CCM
PTCT icon

Cinctive Capital Management’s PTC Therapeutics PTCT Stock Holding History

Cinctive Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Buy
+7,524
New +$543K 0.02% 348
2025
Q4 		– Sell
-95,308
Closed -$5.85M – 498
2025
Q3 		$5.85M Buy
+95,308
New +$4.96M 0.28% 118

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Cinctive Capital Management's PTCT Position: Q2 2026 in Review

Cinctive Capital Management opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 7,524 shares worth $614K. The stake represents 0.02% of the portfolio and ranks #348 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in PTCT as recently as Q3 2025.

Cinctive Capital Management first reported a position in PTCT in Q3 2025 and has held it in 2 quarters since. The position peaked at $5.85M in Q3 2025. 383 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Cinctive Capital Management held 7,524 shares of PTC Therapeutics worth $614K as of Q2 2026.
  • PTC Therapeutics was a new Cinctive Capital Management position in Q2 2026.
  • PTC Therapeutics made up 0.02% of Cinctive Capital Management's portfolio in Q2 2026, its #348 holding.
  • Cinctive Capital Management first reported a position in PTC Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Cinctive Capital Management's PTC Therapeutics position peaked at $5.85M in Q3 2025.
  • 383 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.